EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2026

Published: November 2017
No. of Pages: 38
Price: Single User: US $ 3995  US $ 3196 Corporate User: US $ 11985  US $ 11985
Single User License: US $ 3196
Corporate User License: US $ 11985
ReportsandReports

This report is available at 20% Discount for Single User License till 03 August 2018. To avail discount please contact at +1-888-391-5441 / sales@reportsandreports.com.


EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2026

Summary

Age-related macular degeneration (AMD) is a progressive eye condition that is characterized by the gradual deterioration of the macula, which is the area of the retina responsible for central vision. AMD is the most common cause of significant irreversible vision loss among the elderly (NEI, 2015; NHS, 2015). AMD is classified into three stages: early AMD, intermediate AMD, and late AMD. Early AMD is characterized by the presence of drusen (tiny yellow or white accumulations of extracellular material at the back of the eye) and/or focal pigmentary changes, both of which precede significant visual loss.

The total prevalent cases of AMD in the 7MM will increase from in the 7MM will increase from around 71 million cases in 2016 to almost 83 millioncases in 2026, at an Annual Growth Rate(AGR) of about 1.6% over the forecast period. Throughout the forecast period,Japan will have the highest number of total prevalent cases of AMD, followed by Italy.The total prevalent cases of AMD in Japan and Italy combined will make upapproximately39% of the total prevalent cases of AMD in the 7MM. GlobalData epidemiologists attribute the growth in the total prevalent cases of AMD in the 7MM to the changing population demographics in the respective markets.

The diagnosed incident cases of AMD in the 7MM will increase from around 11.2 million cases in 2016 to nearly 13 million cases in 2026, at an AGR of almost 1.5%. Throughout the forecast period,Japan will have the highest number of diagnosed incident cases of AMD, followed by Italy.The diagnosed incident cases of AMD in Japan and Italy combined will make up approximately40% of the diagnosed incident cases of AMD in the 7MM. GlobalData epidemiologists attribute the growth in the diagnosed incident cases of AMD in the 7MM to the changing population demographics in the respective markets.

The report "EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2026", provides an overview of the risk factors, comorbidities, and the global and historical trends for AMD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).The reportalso includes a 10-year epidemiological forecast for the total prevalent cases of AMD, early AMD, late AMD, late dry AMD, and late wet AMD, all of which are segmented by sex and age (ages 50 years and older) in these markets.

Scope

- The Age-related Macular Degeneration (AMD) EpiCast Report provides an overview of the risk factors and global trends of AMD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- The report also includes a 10-year epidemiological forecast for the total prevalent cases of AMD, early AMD, late AMD, late dry AMD, and late wet AMD, all of which are segmented by sex and age (ages 50 years and older) in these markets. GlobalData epidemiologists also provided the diagnosed incident cases of AMD, early AMD, late AMD, late dry AMD, and late wet AMD, all of which are segmented by sex and age (ages 50 years and older). Additionally, the report includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed incident cases of large drusen (?125 ┬Ám) segmented by sex and age (ages 50 years and older) in these markets.
- The AMD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The AMD EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global AMD market.
- Quantify patient populations in the global AMD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AMD therapeutics in each of the markets covered.
- Understand magnitude of AMD population by type.

Published By: GlobalData
Product Code: GlobalData42063


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy